Russia expected to join top 10 global pharmaceutical markets in 2008, says DSM
The Russian pharmaceutical market is one of the fastest growing in the world. Overall market volume in 2007 amounted to $14.3 billion in terms of retail prices, 16% more than in the previous year.
This made Russia the 11th largest pharmaceutical market in the world. In 2006, growth rates were considerably higher, reaching 30% in the first half of 2008, compared with 15%-20% in earlier years. Although the rate of growth in this sector has decreased, it is still high, given that the international pharmaceutical market expands by 5%-6% on average annually.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
| Headless Content Management with Blaze